Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)
Public ClinicalTrials.gov record NCT02666664. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled, Multicenter Long-term Safety and Tolerability Study of ETC-1002 in Patients With Hyperlipidemia at High Cardiovascular Risk Who Are Not Adequately Controlled by Their Lipid-Modifying Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to see if ETC-1002 (bempedoic acid) is safe and well-tolerated versus placebo in patients with high cardiovascular risk and elevated LDL cholesterol that is not adequately controlled by their current therapy.
Study identification
- NCT ID
- NCT02666664
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 2,230 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 21, 2016 (Actual)
- Primary completion
- Feb 21, 2018 (Actual)
- Completion
- Mar 28, 2018 (Actual)
- Last update posted
- May 11, 2020
2016 – 2018
United States locations
- U.S. sites
- 48
- U.S. states
- 24
- U.S. cities
- 48
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Huntsville | Alabama | — | — |
| Not listed | Cottonwood | Arizona | — | — |
| Not listed | Phoenix | Arizona | — | — |
| Not listed | Canoga Park | California | — | — |
| Not listed | Santa Rosa | California | — | — |
| Not listed | Bridgeport | Connecticut | — | — |
| Not listed | Hartford | Connecticut | — | — |
| Not listed | Atlantis | Florida | — | — |
| Not listed | Boca Raton | Florida | — | — |
| Not listed | Crestview | Florida | — | — |
| Not listed | Crystal River | Florida | — | — |
| Not listed | Daytona Beach | Florida | — | — |
| Not listed | Lake Worth | Florida | — | — |
| Not listed | Miami Lakes | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | Park Ridge | Illinois | — | — |
| Not listed | Iowa City | Iowa | — | — |
| Not listed | Overland Park | Kansas | — | — |
| Not listed | Covington | Kentucky | — | — |
| Not listed | Louisville | Kentucky | — | — |
| Not listed | Minden | Louisiana | — | — |
| Not listed | Monroe | Louisiana | — | — |
| Not listed | Shreveport | Louisiana | — | — |
| Not listed | Auburn | Maine | — | — |
| Not listed | Midland | Michigan | — | — |
| Not listed | Saginaw | Michigan | — | — |
| Not listed | Saint Cloud | Minnesota | — | — |
| Not listed | Tupelo | Mississippi | — | — |
| Not listed | Jefferson City | Missouri | — | — |
| Not listed | Nashua | New Hampshire | — | — |
| Not listed | Bridgewater | New Jersey | — | — |
| Not listed | Cary | North Carolina | — | — |
| Not listed | Mount Airy | North Carolina | — | — |
| Not listed | Raleigh | North Carolina | — | — |
| Not listed | Rocky Mount | North Carolina | — | — |
| Not listed | Wilmington | North Carolina | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Sandusky | Ohio | — | — |
| Not listed | Willoughby | Ohio | — | — |
| Not listed | Hillsboro | Oregon | — | — |
| Not listed | Fort Worth | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Katy | Texas | — | — |
| Not listed | Kingwood | Texas | — | — |
| Not listed | Orem | Utah | — | — |
| Not listed | Richmond | Virginia | — | — |
| Not listed | Puyallup | Washington | — | — |
| Not listed | Tacoma | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 56 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02666664, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 11, 2020 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02666664 live on ClinicalTrials.gov.